Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 897272, 11 pages
http://dx.doi.org/10.1155/2015/897272
Research Article

Neutrophilic Lung Inflammation Suppressed by Picroside II Is Associated with TGF-β Signaling

1School of Korean Medicine, Pusan National University, Yangsan 626-870, Republic of Korea
2Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Chungbuk 363-883, Republic of Korea

Received 1 September 2015; Accepted 15 October 2015

Academic Editor: Yuri Clement

Copyright © 2015 Soohwan Noh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. Rubenfeld, E. Caldwell, E. Peabody et al., “Incidence and outcomes of acute lung injury,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Wheeler and G. R. Bernard, “Treating patients with severe sepsis,” The New England Journal of Medicine, vol. 340, no. 3, pp. 207–214, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Martin and H. J. Silverman, “Gram-negative sepsis and the adult respiratory distress syndrome,” Clinical Infectious Diseases, vol. 14, no. 6, pp. 1213–1228, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. L. B. Tolle and T. J. Standiford, “Danger-associated molecular patterns (DAMPs) in acute lung injury,” The Journal of Pathology, vol. 229, no. 2, pp. 145–156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Bhatia and S. Moochhala, “Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome,” The Journal of Pathology, vol. 202, no. 2, pp. 145–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Alam, D. Stewart, C. Touchard, S. Boinapally, A. M. K. Choi, and J. L. Cook, “Nrf2, a Cap‘n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene,” Journal of Biological Chemistry, vol. 274, no. 37, pp. 26071–26078, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Chan, X.-D. Han, and Y. W. Kan, “An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4611–4616, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Ishii, K. Itoh, H. Sato, and S. Bannai, “Oxidative stress-inducible proteins in macrophages,” Free Radical Research, vol. 31, no. 4, pp. 351–355, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Chan and Y. W. Kan, “Nrf2 is essential for protection against acute pulmonary injury in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 22, pp. 12731–12736, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. Thimmulappa, H. Lee, T. Rangasamy et al., “Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis,” The Journal of Clinical Investigation, vol. 116, no. 4, pp. 984–995, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Boutten, D. Goven, E. Artaud-Macari, J. Boczkowski, and M. Bonay, “NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease,” Trends in Molecular Medicine, vol. 17, no. 7, pp. 363–371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G. L. Bannenberg, N. Chiang, A. Ariel et al., “Molecular circuits of resolution: formation and actions of resolvins and protectins,” Journal of Immunology, vol. 174, no. 7, pp. 4345–4355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Wahl, “Transforming growth factor β: the good, the bad, and the ugly,” The Journal of Experimental Medicine, vol. 180, no. 5, pp. 1587–1590, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Wrana, L. Attisano, R. Wieser, F. Ventura, and J. Massagué, “Mechanism of activation of the TGF-beta receptor,” Nature, vol. 370, no. 6488, pp. 341–347, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Baker and R. M. Harland, “From receptor to nucleus: the Smad pathway,” Current Opinion in Genetics and Development, vol. 7, no. 4, pp. 467–473, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Persson, S. Souchelnytskyi, P. Franzén, K. Miyazono, P. Ten Dijke, and C.-H. Heldin, “Transforming growth factor (TGF-β)-specific signaling by chimeric TGF-β type II receptor with intracellular domain of activin type IIB receptor,” Journal of Biological Chemistry, vol. 272, no. 34, pp. 21187–21194, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-H. Heldin, K. Miyazono, and P. Ten Dijke, “TGF-beta signalling from cell membrane to nucleus through SMAD proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Gordon and G. C. Blobe, “Role of transforming growth factor-beta superfamily signaling pathways in human disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1782, no. 4, pp. 197–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Moustakas, “Smad signalling network,” Journal of Cell Science, vol. 115, part 17, pp. 3355–3356, 2002. View at Google Scholar · View at Scopus
  21. N. An, D. Wang, T. Zhu et al., “Effects of scrocaffeside A from Picrorhiza scrophulariiflora on immunocyte function in vitro,” Immunopharmacology and Immunotoxicology, vol. 31, no. 3, pp. 451–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. J. He, M. Liang, F. F. Hou, Z. J. Guo, D. Xie, and X. Zhang, “Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action,” Journal of Endocrinology, vol. 200, no. 3, pp. 347–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. H. F. Smit, B. H. Kroes, A. J. J. van den Berg et al., “Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 101–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Li, K. Matsunaga, and Y. Ohizumi, “Nerve growth factor-potentiating compounds from Picrorhizae Rhizoma,” Biological and Pharmaceutical Bulletin, vol. 23, no. 7, pp. 890–892, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ghosh and M. Karin, “Missing pieces in the NF-κB puzzle,” Cell, vol. 109, supplement 1, no. 2, pp. S81–S96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Morimitsu, Y. Nakagawa, K. Hayashi et al., “A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway,” The Journal of Biological Chemistry, vol. 277, no. 5, pp. 3456–3463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Malhotra and J. Kang, “SMAD regulatory networks construct a balanced immune system,” Immunology, vol. 139, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. P. Atamas, S. P. Chapoval, and A. D. Keegan, “Cytokines in chronic respiratory diseases,” F1000 Biology Reports, vol. 5, article 3, 2013. View at Publisher · View at Google Scholar
  30. R. L. Doyle, N. Szaflarski, G. W. Modin, J. P. Wiener-Kronish, and M. A. Matthay, “Identification of patients with acute lung injury. Predictors of mortality,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 6, part 1, pp. 1818–1824, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. H. M. Marriott and D. H. Dockrell, “The role of the macrophage in lung disease mediated by bacteria,” Experimental Lung Research, vol. 33, no. 10, pp. 493–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Underhill and A. Ozinsky, “Toll-like receptors: key mediators of microbe detection,” Current Opinion in Immunology, vol. 14, no. 1, pp. 103–110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. U. A. Maus, M. Audrey Koay, T. Delbeck et al., “Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 282, no. 6, pp. L1245–L1252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Wang, X.-H. Liu, H. Chen et al., “Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-kappaB pathway,” Experimental and Therapeutic Medicine, vol. 9, no. 4, pp. 1253–1258, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Massagué and R. R. Gomis, “The logic of TGFbeta signaling,” FEBS Letters, vol. 580, no. 12, pp. 2811–2820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Gorelik and R. A. Flavell, “Transforming growth factor-β in T-cell biology,” Nature Reviews Immunology, vol. 2, no. 1, pp. 46–53, 2002. View at Publisher · View at Google Scholar
  37. T. R. Ulich, S. Yin, K. Guo, E. S. Yi, D. Remick, and J. Del Castillo, “Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation,” American Journal of Pathology, vol. 138, no. 5, pp. 1097–1101, 1991. View at Google Scholar · View at Scopus
  38. L. Shen, J. M. Smith, Z. Shen, M. Eriksson, C. Sentman, and C. R. Wira, “Inhibition of human neutrophil degranulation by transforming growth factor-β1,” Clinical and Experimental Immunology, vol. 149, no. 1, pp. 155–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. K. J. Balazovich, R. Fernandez, V. Hinkovska-Galcheva, S. J. Suchard, and L. A. Boxer, “Transforming growth factor-β1 stimulates degranulation and oxidant release by adherent human neutrophils,” Journal of Leukocyte Biology, vol. 60, no. 6, pp. 772–777, 1996. View at Google Scholar · View at Scopus
  40. F. R. D'Alessio, K. Tsushima, N. R. Aggarwal et al., “CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury,” Journal of Clinical Investigation, vol. 119, no. 10, pp. 2898–2913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Ganeshan, L. K. Johnston, and P. J. Bryce, “TGF-beta1 limits the onset of innate lung inflammation by promoting mast cell-derived IL-6,” Journal of Immunology, vol. 190, no. 11, pp. 5731–5738, 2013. View at Publisher · View at Google Scholar · View at Scopus